- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 259187, 12 pages
Mesenchymal Stem Cell-Like Cells Derived from Mouse Induced Pluripotent Stem Cells Ameliorate Diabetic Polyneuropathy in Mice
1Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan
2Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan
3Division of Diabetes, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan
4Department of CKD Initiatives, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan
5Department of Internal Medicine, School of Dentistry, Aichi-Gakuin University, Nagoya 464-8651, Japan
6Department of Metabolic Medicine, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan
Received 31 July 2013; Accepted 11 September 2013
Academic Editor: Ji Wu
Copyright © 2013 Tatsuhito Himeno et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- K. English, A. French, and K. J. Wood, “Mesenchymal stromal cells: facilitators of successful transplantation?” Cell Stem Cell, vol. 7, no. 4, pp. 431–442, 2010.
- D. K. Wilson, K. M. Bohren, K. H. Gabbay, and F. A. Quiocho, “An unlikely sugar substrate site in the 1.65 Å structure of the human aldose reductase holoenzyme implicated in diabetic complications,” Science, vol. 257, no. 5066, pp. 81–84, 1992.
- P. Xia, R. M. Kramer, and G. L. King, “Identification of the mechanism for the inhibition of Na+,K+-adenosine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2,” Journal of Clinical Investigation, vol. 96, no. 2, pp. 733–740, 1995.
- H. Ishii, M. R. Jirousek, D. Koya et al., “Amelioration of vascular dysfunctions in diabetic rats by an oral PKC β inhibitor,” Science, vol. 272, no. 5262, pp. 728–731, 1996.
- P. A. Craven, R. K. Studer, and F. R. DeRubertis, “Impaired nitric oxide-dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats. Evidence for protein kinase C-mediated suppression of the cholinergic response,” Journal of Clinical Investigation, vol. 93, no. 1, pp. 311–320, 1994.
- D. Koya and G. L. King, “Protein kinase C activation and the development of diabetic complications,” Diabetes, vol. 47, no. 6, pp. 859–866, 1998.
- N. E. Cameron, M. A. Cotter, V. Archibald, K. C. Dines, and E. K. Maxfield, “Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats,” Diabetologia, vol. 37, no. 5, pp. 449–459, 1994.
- L. J. Coppey, J. S. Gellett, E. P. Davidson, J. A. Dunlap, D. D. Lund, and M. A. Yorek, “Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve,” Diabetes, vol. 50, no. 8, pp. 1927–1937, 2001.
- F. Garcia Soriano, L. Virág, P. Jagtap et al., “Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation,” Nature Medicine, vol. 7, no. 1, pp. 108–113, 2001.
- K. Horie, T. Miyata, K. Maeda et al., “Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy,” Journal of Clinical Investigation, vol. 100, no. 12, pp. 2995–3004, 1997.
- I. Giardino, D. Edelstein, and M. Brownlee, “Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes,” Journal of Clinical Investigation, vol. 94, no. 1, pp. 110–117, 1994.
- M. Shinohara, P. J. Thornalley, I. Giardino et al., “Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis,” Journal of Clinical Investigation, vol. 101, no. 5, pp. 1142–1147, 1998.
- A. M. Schmidt, O. Hori, J. X. C. Jing Xian Chen et al., “Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice: a potential mechanism for the accelerated vasculopathy of diabetes,” Journal of Clinical Investigation, vol. 96, no. 3, pp. 1395–1403, 1995.
- M. Lu, M. Kuroki, S. Amano et al., “Advanced glycation end products increase retinal vascular endothelial growth factor expression,” Journal of Clinical Investigation, vol. 101, no. 6, pp. 1219–1224, 1998.
- N. E. Cameron, S. E. M. Eaton, M. A. Cotter, and S. Tesfaye, “Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy,” Diabetologia, vol. 44, no. 11, pp. 1973–1988, 2001.
- L. M. Hinder, A. M. Vincent, C. F. Burant, S. Pennathur, and E. L. Feldman, “Bioenergetics in diabetic neuropathy: what we need to know,” Journal of the Peripheral Nervous System, vol. 17, Supplement s2, pp. 10–14, 2012.
- S. Lupachyk, P. Watcho, N. Hasanova, U. Julius, and I. G. Obrosova, “Triglyceride, nonesterified fatty acids, and prediabetic neuropathy: role for oxidative-nitrosative stress,” Free Radical Biology and Medicine, vol. 52, no. 8, pp. 1255–1263, 2012.
- T. Shibata, K. Naruse, H. Kamiya et al., “Transplantation of bone marrow-derived mesenchymal stem cells improves diabetic polyneuropathy in rats,” Diabetes, vol. 57, no. 11, pp. 3099–3107, 2008.
- K. Naruse, Y. Hamada, E. Nakashima et al., “Therapeutic neovascularization using cord blood-derived endothelial progenitor cells for diabetic neuropathy,” Diabetes, vol. 54, pp. 1823–1828, 2005.
- J.-O. Jeong, M.-O. Kim, H. Kim et al., “Dual angiogenic and neurotrophic effects of bone marrow-derived endothelial progenitor cells on diabetic neuropathy,” Circulation, vol. 119, no. 5, pp. 699–708, 2009.
- H. Kim, J.-S. Park, J. C. Yong et al., “Bone marrow mononuclear cells have neurovascular tropism and improve diabetic neuropathy,” Stem Cells, vol. 27, no. 7, pp. 1686–1696, 2009.
- T. Okawa, H. Kamiya, T. Himeno, J. Kato, Y. Seino, et al., “Transplantation of neural crest like cells derived from induced pluripotent stem cells improves diabetic polyneuropathy in mice,” Cell Transplantation, vol. 22, no. 10, pp. 1767–1783, 2013.
- K. Takahashi and S. Yamanaka, “Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors,” Cell, vol. 126, no. 4, pp. 663–676, 2006.
- T. Awaya, T. Kato, Y. Mizuno, H. Chang, A. Niwa, et al., “Selective development of myogenic mesenchymal cells from human embryonic and induced pluripotent stem cells,” PLoS ONE, vol. 7, Article ID e51638, 2012.
- Y. S. Chen, R. A. Pelekanos, R. L. Ellis, R. Horne, E. J. Wolvetang, et al., “Small molecule mesengenic induction of human induced pluripotent stem cells to,” Stem Cells Translational Medicine, vol. 1, pp. 83–95, 2012.
- I. Eberle, M. Moslem, R. Henschler, and T. Cantz, “Engineered MSCs from patient-specific iPS cells,” Advances in Biochemical Engineering/Biotechnology, 2012.
- X.-H. Cao, H. S. Byun, S.-R. Chen, and H.-L. Pan, “Diabetic neuropathy enhances voltage-activated Ca2+ channel activity and its control by M4 muscarinic receptors in primary sensory neurons,” Journal of Neurochemistry, vol. 119, no. 3, pp. 594–603, 2011.
- R. L. Williams, D. J. Hilton, S. Pease et al., “Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells,” Nature, vol. 336, no. 6200, pp. 684–687, 1988.
- S. Chateauvieux, J.-L. Ichanté, B. Delorme et al., “Molecular profile of mouse stromal mesenchymal stem cells,” Physiological Genomics, vol. 29, no. 2, pp. 128–138, 2007.
- M. Chopp and Y. Li, “Treatment of neural injury with marrow stromal cells,” The Lancet Neurology, vol. 1, no. 2, pp. 92–100, 2002.
- J. J. Katims, E. H. Naviasky, and L. K. Y. Ng, “New screening device for assessment of peripheral neuropathy,” Journal of Occupational Medicine, vol. 28, no. 12, pp. 1219–1221, 1986.
- V. Neirinckx, C. Coste, B. Rogister, and S. Wislet-Gendebien, “Concise review: adult mesenchymal stem cells, adult neural crest stem cells, and therapy of neurological pathologies: a state of play,” Stem Cells Translational Medicine, vol. 2, pp. 284–296, 2013.
- D. D. Houlihan, Y. Mabuchi, S. Morikawa, K. Niibe, D. Araki, et al., “Isolation of mouse mesenchymal stem cells on the basis of expression of Sca-1 and PDGFR-alpha,” Nature Protocols, vol. 7, pp. 2103–2111, 2012.
- J. M. Hare, J. E. Fishman, G. Gerstenblith, D. L. DiFede Velazquez, J. P. Zambrano, et al., “Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells,” Journal of the American Medical Association, vol. 308, pp. 2369–2379, 2012.
- S. H. Chou, S. Z. Lin, C. H. Day, W. W. Kuo, C. Y. Shen, et al., “Mesenchymal stem cell insights: prospects in hematologic transplantation,” Cell Transplantation, vol. 22, no. 4, pp. 711–721, 2013.
- Y. Zhang, S. Liao, M. Yang, X. Liang, M. W. Poon, et al., “Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension,” Cell Transplantation, vol. 21, pp. 2225–2239, 2012.
- K. Brown, S. Xie, X. Qiu, M. Mohrin, J. Shin, et al., “SIRT3 reverses aging-associated degeneration,” Cell Reports, vol. 3, pp. 319–327, 2013.
- M. E. Carlson, C. Suetta, M. J. Conboy et al., “Molecular aging and rejuvenation of human muscle stem cells,” EMBO Molecular Medicine, vol. 1, no. 8-9, pp. 381–391, 2009.
- A. Banito and J. Gil, “Induced pluripotent stem cells and senescence: learning the biology to improve the technology,” EMBO Reports, vol. 11, no. 5, pp. 353–359, 2010.
- L. Lapasset, O. Milhavet, A. Prieur et al., “Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state,” Genes and Development, vol. 25, no. 21, pp. 2248–2253, 2011.
- Y. Pan and S. Cai, “Current state of the development of mesenchymal stem cells into clinically applicable Schwann cell transplants,” Molecular and Cellular Biochemistry, vol. 368, pp. 127–135, 2012.
- T. Terashima, H. Kojima, M. Fujimaya et al., “The fusion of bone-marrow-derived proinsulin-expressing with nerve cells underlies diabetic neuropathy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 35, pp. 12525–12530, 2005.